HIV PrEP | Pep Coll, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

New delivery systems and long acting antiretroviral drugs | David Back, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

The EpiTer-2 database | Robert Flisiak, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Liver transplantation for HCV and HBV in The Czech Republic | Soña Frankova, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Clinical considerations in switching antiretroviral therapy | David Jilich, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Treatment-experienced patients in Central and Eastern Europe – What needs to be done? | Viktor Aster, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

HIV & women’s health: do we have any game changers here? | Mariana Mărdărescu, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Hepatitis Delta: what are the new developments, what are the challenges? | Cihan Yurdaydin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Update on changes in Hepatitis B and C in CEE countries | Miłosz Parczewski, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Epidemiology of HIV Infection and Treatment in Europe | Teymur Noori, MSc

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018